10:00 AM EST - Sernova Corp. : Announced today it has entered into a service agreement with the Centre for Commercialization of Regenerative Medicine to establish, optimize and validate Sernova's licensed technology for creating stem cell derived therapeutic cells that produce insulin and are glucose responsive. Sernova Corp.
shares V.SVA are trading down $0.01 at $0.26.
